OCA2 and urinary bladder carcinoma: According to Iida and coworkers, the anticancer potential of luteolin against human bladder cancer cell line T24 was due to induction cell‐cycle arrest at G2/M, downregulation of p‐S6, suppression of cell survival, upregulation of p21 and TRX1, reduction in ROS levels.